* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Molecular Biology & Medicine
Survey
Document related concepts
Genetic engineering wikipedia , lookup
Developmental biology wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene therapy wikipedia , lookup
Personalized medicine wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Human genetic resistance to malaria wikipedia , lookup
Germ theory of disease wikipedia , lookup
List of types of proteins wikipedia , lookup
Somatic evolution in cancer wikipedia , lookup
Neurogenetics wikipedia , lookup
Oncogenomics wikipedia , lookup
Point mutation wikipedia , lookup
Transcript
Molecular Biology & Medicine Figure 16.13 a bacterial expression vector produces lots of the protein encoded by a cloned gene Figure 16.14 strategy for the production of a therapeutic protein Gleevec, designed atom by atom, is a treatment for CML p. 339 Medical Problems Accessible to Molecular Biology • “One Gene - One Disease” – diseases due to single polypeptides • enzymes of phenylalanine metabolism –alkaptonuria –phenylketonuria (PKU) two defects in phenylalanine catabolism result in different heritable diseases Figure 17.1 Medical Problems Accessible to Molecular Biology • “One Gene - One Disease” – diseases due to single polypeptides • hemoglobin - a carrier protein –sickle cell disease –hemoglobin C disease –hemoglobin E disease Figure 17.2 Figure 17.3 Medical Problems Accessible to Molecular Biology • “One Gene - One Disease” – diseases due to single polypeptides • membrane proteins - receptors & transporters –familial hypercholesterolemia –cystic fibrosis Medical Problems Accessible to Molecular Biology • “One Gene - One Disease” – diseases due to single polypeptides • structural proteins –Duchenne muscular dystrophy »cells lack dystrophin –hemophilia »blood lacks coagulation protein Medical Problems Accessible to Molecular Biology • “One Gene - One Disease” – diseases due to single polypeptides • misfolded protein –Transmissible spongiform encephalopathies, prion diseases »Scrapie, “mad cow”, KruetzfeldJacob, kuru »transmitted by a protein Figure 17.4 normal misfolded Medical Problems Accessible to Molecular Biology • molecular analysis requires isolation of the affected gene(s) – human genomic libraries can be screened with sequence-specific probes • deduced from protein sequence • from mRNA • from other species • identified by a “positional” clue sequences derived from genes or linked to genes can be used to isolate the genes Figure 17.6 RFLPs serve as natural genetic markers that can be linked to genes Figure 17.7 Heritable Diseases Arise by Mutation • mutations result from a variety of causes – point mutations may be spontaneous or induced • 5-methylcytosine => thymine mutations 5-mCAA or 5-mCAG =>TAA or TAG glutamine => stop 5-mCGA=>TGA arginine => stop the uracil repair system does not recognize a 5-MeC=>T mutation Figure 17.8 Heritable Diseases Arise by Mutation • mutations result from a variety of causes – point mutations may be spontaneous or induced • silent - no disease • missense - disease possible • nonsense - disease probable Heritable Diseases Arise by Mutation • mutations result from a variety of causes – large-scale deletion may remove • part of a gene • all of a gene • several neighboring genes – inversion or translocation may • interrupt a gene • create a new gene a hybrid enzyme: part bcr (chr 22) an active protein Kinase p. 339 and part abl (chr 9) Heritable Diseases Arise by Mutation • mutations result from a variety of causes – expanding triplet repeats may cause progressive heritable diseases • Fragile-X syndrome ~30 CGG repeats - normal 50-200 repeats - “premutated” 200-1300 repeats - cytosine methylation, gene inactivation, mental retardation 18-162 bp 165-600 bp 600-6000 bp FMR1 promoter region Figure 17.9 Fragile-X at metaphase Figure 17.5 Heritable Diseases Arise by Mutation • mutations result from a variety of causes – expanding triplet repeats may cause progressive heritable diseases • Fragile-X syndrome - CGG repeats • Myotonic dystrophy - CTG repeats • Huntington’s disease - CAG repeats • > 9 others, so far… – … or not Molecular Diagnosis: Before the Disease • genetically characterized diseases can be detected by various tests – phenotypic screens • PKU preliminary screen the heel-stick test identifies infants for more testing Figure 17.10 possible PKU bacteria that require phe grow on PKU blood, don’t on normal Blood Figure 17.10 detection of sickle cell allele by RFLP with a specific restriction enzyme Figure 17.11 MstII recognizes …CCTNAGG… The sickle cell allele has …CCTGTGG… Molecular Diagnosis: Before the Disease • genetically characterized diseases can be detected by various tests – phenotypic screens – genotypic screens • identification of known disease-causing alleles –allele-specific RFLPs –allele-specific hybridization detection of sickle cell allele by allelespecific hybridization Figure 17.12 Cancer - A Disease of Genetic Changes • cancer cells differ from normal cells – division without normal signals to divide – division in spite normal signals not to divide Cancer - A Disease of Genetic Changes • tumor types differ – benign • slow-growing, localized, like source tissue – malignant • dedifferentiated cells Figure 17.13 Cancer - A Disease of Genetic Changes • tumor types differ – benign • slow-growing, localized, like source tissue – malignant • dedifferentiated cells – metastatic • express digestive enzymes • fail to make cell adhesion proteins • cause vascularization Cancer - A Disease of Genetic Changes • tumor types differ – different tissues • carcinomas: epithelial (lung, breast, colon, liver) • sarcomas: deep tissues (bone, blood vessels, muscle) • leukemias, lymphomas: blood stem cells Viral agents in cancer Table 17.1 Cancer - A Disease of Genetic Changes • varied causes – viruses (~15%) • combined with specific mutations – most cancers (~85%) begin with somatic mutations • dividing cells are most susceptible to mutational consequences mutations in dividing cells produce mutant cell populations Figure 17.14 Cancer - A Disease of Genetic Changes • two types of genes can lead to cancer – proto-oncogenes • normally stimulate cell division –growth factors –growth factor receptors –signal transduction components –transcription factors • usually dominant mutations protooncogenes normally stimulate cell division Figure 17.15 Cancer - A Disease of Genetic Changes • two types of genes can lead to cancer – tumor-suppressor genes • normally regulate cell division –cell-adhesion proteins –DNA repair proteins –cell cycle control proteins • generally recessive mutations Figure 17.17 tumor-suppressor mutations are recessive Figure 17.16 Cancer - A Disease of Genetic Changes • metastatic cancers involve the accumulation of many defects Figure 17.18 -TS APC +OG ras -TS DCC five mutations of tumor suppressor genes or proto-oncogenes lead to -TS p53 polyp, benign tumor, class II & III adenomas, malignant tumor +telomerase, & -adhesion, etc. metastatic cancer cytotoxic treatments can be used to control the spread of cancer Figure 17.19 Treatment of Genetic Diseases • modify the phenotype – restrict toxic substrates - PKU – metabolic inhibition - block cholesterol synthesis – kill targeted cells - treat cancer with chemicals that kill fast-growing cells – administer missing protein - insulin, clotting factor example of ex vivo gene therapy Figure 17.20 Treatment of Genetic Diseases • Gene Therapy – ex vivo • remove cells from patient • repair defect in cells • return cells to patient but • returned cells eventually die, so • altered stem cells may serve as a permanent source of new cells Treatment of Genetic Diseases • Gene Therapy – in vivo • repair cells in patient • requires a delivery method –dispersal –gene delivery Figure 17.22 Figure 17.23 many human genes are alternatively spliced Figure 17.24 rapid production of designer pharmaceuticals • plant viral expression vectors – a host plant is infected with an engineered virus carrying a gene for a specific product – the same host species can produce protein from any gene placed in a viral vector – designer phamaceuticals are produced in months rather than years